Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Association between β-blocker use and reduced mortality after vascular surgery in patients with kidney disease

Nature Clinical Practice Nephrology volume 4, pages 128–129 (2008)Cite this article

boxed-textWelten GM et al. (2007) β-Blockers improve outcomes in kidney disease patients having noncardiac vascular surgery. Kidney Int 72: 1527–1534

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Schrier RW (2006) Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol 47: 1–8

    Article  Google Scholar 

  2. Guerin AP et al. (2004) Cardiovascular disease in renal failure. Minerva Urol Nefrol 56: 279–288

    CAS  PubMed  Google Scholar 

  3. Hackam DG (2006) Perioperative beta-blocker therapy in vascular surgery: clinical update. J Vasc Surg 43: 632–634

    Article  Google Scholar 

  4. Mancia G et al. (2007) 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 25: 1751–1762

    Article  CAS  Google Scholar 

  5. Kanno Y et al. (2004) Clinical strategy for the treatment of hypertension in non-diabetic and diabetic nephropathy in Japan. Contrib Nephrol 143: 145–158

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Saitama Medical University, Department of Nephrology, 38 Morohongo, Moroyama-machi, Irumagun, Saitama 350-0495, Japan iromichi@saitama-med.ac.jp

Authors and Affiliations

  1. H Suzuki is a Professor in the Department of Nephrology and Vice Chairman of the Community Health Science Center at Saitama Medical University, Saitama, Japan.,

    Hiromichi Suzuki

Authors
  1. Hiromichi Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Suzuki, H. Association between β-blocker use and reduced mortality after vascular surgery in patients with kidney disease. Nat Rev Nephrol 4, 128–129 (2008). https://doi.org/10.1038/ncpneph0708

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0708

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing